Biosimilars, Beginning a Conversation

Phoenix, AZ US
November 7, 2015

Learning Objectives

  • Discuss the history and importance of biosimilars in oncology
  • Describe the current landscape of biotherapeutics in oncology
  • Discuss the current pathway for US Food and Drug Administration (FDA) approval of biosimilars
  • Define the potential clinical implications associated with biosimilars and biotherapeutics for advanced practitioners working in oncology
Course summary
Available credit: 
  • 1.00 AANP
  • 0.83 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/07/2015
Course expires: 
03/31/2016
Event starts: 
11/07/2015 - 8:00am
Event ends: 
11/07/2015 - 9:00am
Cost:
$0.00
Parent activity set: 
Rating: 
0
JW Marriott Desert Ridge
5350 East Marriott Drive
Phoenix, AZ 85054
United States

Chris Campen, PharmD, BCPS, BCOP
Ali McBride, PharmD, BCPS, BCOP
Kelley Mayden, MSN, FHP, AOCNP

Available Credit

  • 1.00 AANP
  • 0.83 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.